武田(Takeda Pharmaceutical) 武田与其合作伙伴和黄医药所共同开发的药物Fruzaqla(呋喹替尼/fruquintinib)在去年11月获得美国FDA的,治疗特定的结直肠癌患者。这个月初,美国FDAEohilia(布地奈德口服混悬液)上市,治疗11岁以上嗜酸性粒细胞性食管炎(EoE)患者。新闻稿指出,这是FDA批准治疗EoE的首款口服疗法,有望解决患...
武田(Takeda Pharmaceutical) 武田与其合作伙伴和黄医药所共同开发的药物Fruzaqla(呋喹替尼/fruquintinib)在去年11月获得美国FDA的批准上市,治疗特定的结直肠癌患者。这个月初,美国FDA批准Eohilia(布地奈德口服混悬液)上市,治疗11岁以上嗜酸性粒细胞性食管...
JoinHub Pharma is one of the top pharmaceutical companies in India. We are a leading pharmaceuticals manufacturer provides generic medicine & others.
We dive into the high-growth life sciences sector, ranking the 15 top-funded biotech companies and pharmaceutical startups in the UK.
The below list of the top 10 biggest pharma companies in the world in 2024 is ranked by 2023 revenue for pharmaceutical sales only. 1. Pfizer - US$58.5bn 2. Johnson & Johnson - US$54.76bn 3. AbbVie - US$54.32bn 4. Merck & Co - US$53.6bn 5. Roche - US$49.9bn 6. Sanofi - ...
Biobrick Pharma Welcome ToBiobrick Pharma Biobrick Pharma is an innovative sourcing & distribution company, involved in both exclusive representation and global supply of a wide range of quality pharmaceutical formulation. Alot years of experience and success in the industry, Biobrick Pharma has ...
2021年6月10日,《PharmExec》(美国制药经理人杂志)发布的2021年全球制药企业TOP50榜单显示,前十依次为:罗氏、诺华、艾伯维、强生、百时美施贵宝、默沙东、赛诺菲、辉瑞、葛兰素史克、武田。与2020年相比,罗氏、诺华、百时美施贵宝、赛诺菲、葛兰素史克、武田的排名未变,艾伯维由第八变成第三,辉瑞由第三变成第八,强生...
3、BioMarin Pharmaceutical 该公司创立于1996年,总部位于美国加州,一家全球性的生物技术公司,为患有严重和危及生命的罕见疾病患者开发创新疗法。该公司拥有7个商业化药物和多个临床和临床前候选药物。其管线中的候选基因疗法包括: 1)Valoctocogene Roxaparvovec,这是一种基于AAV的基因疗法,正处于2个III期临床研究GENEr...
Analysis at Northeastern university in Boston,MA. Founded by thought leaders in clinical development, regulatory strategy, and advanced analytics,Bioanaytix is working wiht leading Pharmaceutical partners to advance, improve and accelerate the development and commercialization of biologic and biosimilar drugs...
Drakulich, Angie